期刊论文详细信息
International Journal of Clinical and Experimental Medicine
Effect of Second mitochondria-derived activator of caspase in combination with Docetaxel on lung cancer cell A549
Xiao-Mei Li1  Chuan-Liang Peng1  Wen Zou1  Yong-Wei Yang1  Cheng-Yu Jin1  Xiao-Kaiti Maimaitiyiming1  Yu-Hua Jiang1 
关键词: Second mitochondria-derived activator of caspase;    lung cancer;    Docetaxel;    apoptosis;    cloning ability;   
DOI  :  
学科分类:医学(综合)
来源: e-Century Publishing Corporation
PDF
【 摘 要 】

This study was to investigate inhibiting effect of structurally unique Second mitochondria-derived activator of caspase (Smac) in combination with Docetaxel on lung cancer cell line A549. Results showed that the expression of Smac in transfected A549 cells was higher than the control cells both at mRNA level and protein level (P<0.05). Smac over-expression induced a little apoptosis, however, when treated with Docetaxel together, the cells showed a higher apoptosis rate. The apoptosis rate was significantly increased in Smac + Docetaxel group when compared with that in Smac group and Docetaxel group (P<0.05). Cells cloning ability in Smac + Docetaxel group was worse than that of other groups (P<0.05), cell mass formed in relatively small quantities and sparse location. Thus, over-expression of Smac increases the sensitivity of lung cancer A549 cells to Docetaxel treatment, and transfection of Smac to tumor cells might provide a potential therapy modality.

【 授权许可】

Unknown   

【 预 览 】
附件列表
Files Size Format View
RO201912140865476ZK.pdf 703KB PDF download
  文献评价指标  
  下载次数:25次 浏览次数:1次